Jill Czarnecki

Jill Czarnecki serves as a key procurement professional within the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical research. She manages the acquisition of specialized biological products and laboratory-developed diagnostic technologies critical to operational readiness in austere environments. Her portfolio centers on high-complexity contracts for research-grade reagents, pathogen detection systems, and field-deployable medical countermeasures, ensuring that Navy and Marine Corps personnel have access to cutting-edge, validated medical solutions. Czarnecki’s work directly enables the Center’s strategic priorities in infectious disease surveillance and rapid diagnostic innovation. Her primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted vendor with deep expertise in biological product manufacturing and GMP-compliant production of research and diagnostic materials. Czarnecki maintains a consistent, long-term partnership with this firm, relying on its technical capabilities to deliver compliant, high-purity biological reagents and proprietary assay components. Her contracting approach emphasizes technical specificity, regulatory adherence, and supply chain reliability, favoring vendors with proven experience in federal biomedical procurement and validated quality systems. Czarnecki’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a mission-driven focus on technical capability over socioeconomic preferences, prioritizing the most qualified supplier regardless of business size or certification. While small business participation is not formally incentivized in her portfolio, her evaluations consistently reward technical merit, regulatory compliance, and proven performance in high-stakes biomedical environments. Her primary NAICS classification is 325414—Biological Product (except Diagnostic) Manufacturing—indicating a narrow, highly specialized focus on the procurement of research-grade biological materials, including cell cultures, purified proteins, and synthetic antigens. She procures products used in infectious disease research, vaccine development, and point-of-care diagnostics, requiring deep familiarity with FDA-regulated manufacturing standards and biosafety protocols. Her expertise lies at the intersection of biomedical science and federal acquisition, ensuring that critical research tools meet exacting military and scientific requirements.